Oncolytic potential of rodent parvoviruses for cancer therapy in humans: a brief review.

@article{Geletneky2005OncolyticPO,
  title={Oncolytic potential of rodent parvoviruses for cancer therapy in humans: a brief review.},
  author={Karsten Geletneky and Marta Herrero Y Calle and Jean Rommelaere and Joerg R. Schlehofer},
  journal={Journal of veterinary medicine. B, Infectious diseases and veterinary public health},
  year={2005},
  volume={52 7-8},
  pages={
          327-30
        }
}
Summary Rodent parvoviruses are promising candidates for oncolytic virotherapy of cancer in humans because of their oncotropism (preferential killing of transformed cells) in the absence of pathogenicity. Here, we give an overview concerning the possible application of parvovirus H-1 for cancer therapy, with specific emphasis on malignant brain tumours in humans. 

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 12 CITATIONS

Virotherapy in Cancer

  • Iranian journal of cancer prevention
  • 2013
VIEW 1 EXCERPT

Parvovirus H1 selectively induces cytotoxic effects on human neuroblastoma cells.

  • International journal of cancer
  • 2010
VIEW 2 EXCERPTS
CITES BACKGROUND